CFON-026
Product Specifications
CAS Number
2941611-57-8
Target
BTK
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
CFON-026 is a selective, orally active, non-covalent BTK inhibitor with an IC50 of 0.27 nM. It demonstrates significant antitumor activity against wild-type BTK (TMD8 and REC-1) as well as all clinically relevant BTK resistance mutations (BTKC481S, T474I, L528W, and V416L) . CFON-026 induces complete tumor regression in the TMD8 xenograft mouse model. This compound is applicable for research into hematologic cancers, such as chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
Smiles
NC=1C=2N3C([C@]4(C[C@](NC(=O)CCCCC\C=C\C3=CN1)(CCC4)[H])[H])=NC2C5=CC=C(C(NC6=CC(C#N)=CC=N6)=O)C=C5
Molecular Formula
C33H34N8O2
Molecular Weight
574.68
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
044003-AP 200 µL
ZBTB44, CT (ZBTB44, BTBD15, ZNF851, Zinc finger and BTB domain-containing protein 44, BTB/POZ domain-containing protein 15, Zinc finger protein 851) (AP) discontinued
Sign In for Pricing
View Details H9424 96 Tests
Tumor Necrosis Factor Receptor superfamily member 16 (NGFR) Mouse ELISA Kit
Sign In for Pricing
View Details 
MBS6183531-01 0.1 mL
LASS1 (LAG1 Homolog, Ceramide Synthase 1, CerS1, LAG1, MGC90349, UOG1) (HRP)
Sign In for Pricing
View Details